Measuring What Matters: How to Track and Improve HCP Engagement ROI

HCP Engagement & Activation Oncology & Hematology Post-launch
Sarah Heming
VP of Strategic Marketing at Diaceutics
Brand Strategy
Connect
hcp insight moment pair

Pharma marketers are under growing pressure to prove that their campaigns do more than generate awareness, they must drive prescribing behavior, improve patient outcomes, and deliver measurable return on investment (ROI). Yet, 26% of marketers cite measuring campaign effectiveness as a top challenge, especially when trying to link spend to therapy adoption, (UP, 2024). 

In a landscape where billions are spent on HCP engagement annually, the ability to measure what truly matters is no longer optional; it’s a commercial imperative. 

Why traditional metrics fall short

For years, pharma marketing has relied on surface-level metrics: impressions, opens, and attendance rates. These indicators offer a snapshot of reach, but they rarely reflect clinical relevance or behavioral change. As Sophie Peoples, Head of Oncology Digital Data at GSK, noted in a recent Fierce Biotech webinar, “Engagement success isn’t just about frequency—it’s about understanding how physicians interact with content and how that converts into clinical action.” 

Fierce Biotech & Diaceutics. (2025).Data-Driven Targeting and HCP Education: Engaging Physicians Within the Critical Treatment Decision Window [Webinar]. Featuring Sophie Peoples, GSK. 

Leading indicators like content views are useful, but lagging indicators, such as diagnostic test orders or therapy initiation, are what truly define ROI. 

  

A New KPI Framework for HCP Engagement 

To move beyond surface-level analytics, pharma marketers must adopt a KPI framework that links engagement to outcomes. Diaceutics recommends tracking across three tiers: 

  • Engagement Quality
  • Content interaction rates 
  • Channel preference and responsiveness
  • Peer-led content performance
  • Prescriber Behavior Change
  • Diagnostic test ordering rates 
  • Therapy initiation following engagement 
  • Shifts in prescribing patterns over time
  • Commercial Impact
  • Therapy adoption by region or specialty
  • Prescription volume growth
  • ROI per engagement touchpoint 
This framework enables marketers to connect the dots between campaign activity and clinical action, turning engagement into measurable influence. 

How Physician Engage Powers Performance 

Diaceutics’ Physician Engage platform is designed to operationalize this framework. By combining diagnostic intelligence with real-time HCP targeting, it enables:

  • Trigger-based outreach within 24 hours of a qualifying diagnostic event 
  • Personalized content delivery aligned with the physician’s current patient context
  • Outcome tracking that links engagement to testing and treatment decisions Content interaction rates 
Measuring HCP engagement effectively means shifting focus from volume to value. It’s not enough to know how many physicians saw a message; we need to understand whether that message influenced their clinical thinking, prompted diagnostic action, or supported a treatment decision. This is where leading indicators like content views must be complemented by lagging indicators such as test orders and therapy starts. When engagement is aligned with clinical relevance and delivered at the right moment, it becomes a catalyst for better care, not just a marketing metric. 

Industry Insights: What the Data Tells Us  

Fierce Pharma reports that demonstrating ROI is the top challenge for digital HCP engagement, cited by 69% of pharma companies (Fierce Pharma, 2025). 

This insight underscore the urgency of building smarter measurement models, ones that reflect the complexity of the HCP journey and the real-world impact of engagement.

Putting Patients at the Center

Ultimately, measuring HCP engagement isn’t just about optimizing spend, it’s about ensuring that patients receive timely, appropriate care. Every click, view, or interaction should be a step toward better treatment decisions. Physician Engage helps marketers align their efforts with this goal, ensuring that every campaign contributes to meaningful clinical outcomes. 

Let’s Measure What Matters 

If your team is ready to move beyond vanity metrics and build a performance model that reflects real-world impact, Diaceutics can help.  

Reach out to explore how Physician Engage can support smarter engagement, stronger ROI, and better patient outcomes.

About Diaceutics

We’ve been with pharma and biotech companies for over 20 years, helping them to make more informed diagnostic and therapeutic decisions based on real-world data. Our platforms and tools provide global insight from a network of laboratories across 50+ countries.


This unparalleled visibility into real-world testing helps support therapy programs across oncology, cardiology, neurology, autoimmune, rare diseases, and many more.

Contact us

FAQs

Why is measuring HCP engagement so challenging for pharma marketers?
Traditional campaigns are easy to run but hard to prove. In fact, 26% of marketers cite measuring campaign effectiveness as a top challenge, especially when linking spend to therapy adoption (UP, 2024). With billions spent on HCP engagement annually, the ability to measure what truly matters has become a commercial imperative, not an option.
Why do traditional marketing metrics fall short?
Metrics like impressions, opens, and attendance rates offer a snapshot of reach, but they rarely reflect clinical relevance or behavioural change. As GSK's Sophie Peoples put it, engagement success "isn't just about frequency—it's about understanding how physicians interact with content and how that converts into clinical action." Leading indicators show interest; lagging indicators like test orders and therapy initiation define ROI.
What KPIs should pharma marketers actually track?
Diaceutics recommends a three-tier KPI framework: Engagement Quality (content interaction, channel responsiveness, peer-led performance), Prescriber Behaviour Change (diagnostic test ordering, therapy initiation, shifts in prescribing patterns), and Commercial Impact (therapy adoption by region, prescription volume growth, and ROI per engagement touchpoint). Together, these connect campaign activity to genuine clinical action.
What is Physician Engage and how does it help?
Physician Engage is Diaceutics' platform that operationalises this KPI framework by combining diagnostic intelligence with real-time HCP targeting. It enables trigger-based outreach within 24 hours of a qualifying diagnostic event, delivers content aligned with the physician's current patient context, and tracks outcomes that link engagement directly to testing and treatment decisions.
How does data-driven engagement improve patient outcomes?
When engagement is aligned with clinical relevance and delivered at the right moment, it becomes a catalyst for better care rather than just a marketing metric. By shifting focus from volume to value, marketers can ensure every click, view, or interaction moves a patient closer to timely, appropriate treatment.
What does the wider industry say about proving ROI?
The pressure is industry-wide. Fierce Pharma reports that demonstrating ROI is the top challenge for digital HCP engagement, cited by 69% of pharma companies (Fierce Pharma, 2025). This underscores the urgency of building smarter measurement models that reflect the complexity of the HCP journey and the real-world impact of engagement.
Written By Sarah Heming
Sarah Heming is Interim VP of Strategic Marketing at Diaceutics, where she leads brand strategy and global marketing to help pharma and biotech partners bring diagnostic-driven therapies to more eligible patients. A senior marketing and communications leader with more than two decades across Fortune 500 and highly regulated industries, she has driven transformative growth, award-winning product launches and high-impact corporate rebrands. Sarah previously held marketing leadership roles at Zoetis, Mölnlycke Health Care and Abbott, bringing deep expertise in brand building, stakeholder engagement and omnichannel strategy.
Read more by this author
HCP Engagement & Activation Oncology & Hematology Post-launch
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.